These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

859 related items for PubMed ID: 31985099

  • 1. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A, Tanino T, Yamaguchi T, Hirota K, Saito S, Okada N, Akioka H, Shinohara T, Yufu K, Takahashi N.
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [Abstract] [Full Text] [Related]

  • 2. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E, Ren X, Steinberg BA, Green CL, Barnett AS, Rosa NS, Al-Khatib SM, Atwater BD, Daubert JP, Frazier-Mills C, Grant AO, Hegland DD, Jackson KP, Jackson LR, Koontz JI, Lewis RK, Sun AY, Thomas KL, Bahnson TD, Piccini JP.
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [Abstract] [Full Text] [Related]

  • 3. Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.
    Schupp T, Schmitt A, Reinhardt M, Abel N, Lau F, Abumayyaleh M, Dudda J, Weidner K, Ayoub M, Akin M, Müller J, Akin I, Behnes M.
    Eur J Prev Cardiol; 2024 Aug 22; 31(11):1372-1384. PubMed ID: 38825871
    [Abstract] [Full Text] [Related]

  • 4. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.
    Yamauchi R, Morishima I, Okumura K, Kanzaki Y, Morita Y, Takagi K, Nagai H, Watanabe N, Furui K, Yoshioka N, Miyazawa H, Shimojo K, Imaoka T, Sakamoto G, Murohara T.
    Europace; 2021 Aug 06; 23(8):1252-1261. PubMed ID: 33693617
    [Abstract] [Full Text] [Related]

  • 5. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).
    Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, Goromonzi F, Sawhney V, Duncan E, Page SP, Ullah W, Unsworth B, Mayet J, Dhinoja M, Earley MJ, Sporton S, Schilling RJ.
    Circ Arrhythm Electrophysiol; 2014 Feb 06; 7(1):31-8. PubMed ID: 24382410
    [Abstract] [Full Text] [Related]

  • 6. Comparison of His-Purkinje Conduction System Pacing with Atrial-Ventricular Node Ablation and Pharmacotherapy in HFpEF Patients with Recurrent Persistent Atrial Fibrillation (HPP-AF study).
    Zhang JF, Pan YW, Li J, Kong XG, Wang M, Xue ZM, Gao J, Fu GS.
    Cardiovasc Drugs Ther; 2024 Aug 06; 38(4):847-858. PubMed ID: 36749453
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes.
    Younis A, Tabaja C, Santangeli P, Nakagawa H, Sipko J, Madden R, Bouscher P, Taigen T, Higuchi K, Hayashi K, El Hajjar AH, Chamseddine F, Callahan T, Martin DO, Nakhla S, Kanj M, Sroubek J, Lee JZ, Saliba WI, Wazni OM, Hussein AA.
    Circ Arrhythm Electrophysiol; 2024 Sep 06; 17(9):e012926. PubMed ID: 39193716
    [Abstract] [Full Text] [Related]

  • 8. Relationships between maintenance of sinus rhythm and clinical outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation.
    Machino-Ohtsuka T, Seo Y, Ishizu T, Yamamoto M, Hamada-Harimura Y, Machino T, Yamasaki H, Sekiguchi Y, Nogami A, Aonuma K, Ieda M.
    J Cardiol; 2019 Sep 06; 74(3):235-244. PubMed ID: 30910388
    [Abstract] [Full Text] [Related]

  • 9. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    Ichijo S, Miyazaki S, Kusa S, Nakamura H, Hachiya H, Kajiyama T, Iesaka Y.
    J Cardiol; 2018 Sep 06; 72(3):240-246. PubMed ID: 29609877
    [Abstract] [Full Text] [Related]

  • 10. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
    Kuck KH, Merkely B, Zahn R, Arentz T, Seidl K, Schlüter M, Tilz RR, Piorkowski C, Gellér L, Kleemann T, Hindricks G.
    Circ Arrhythm Electrophysiol; 2019 Dec 06; 12(12):e007731. PubMed ID: 31760819
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR®) Research to Practice (R2P) Project.
    Mathew JS, Marzec LN, Kennedy KF, Jones PG, Varosy PD, Masoudi FA, Maddox TM, Allen LA.
    J Am Heart Assoc; 2017 Aug 11; 6(8):. PubMed ID: 28862932
    [Abstract] [Full Text] [Related]

  • 13. A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design.
    Parkash R, Wells G, Rouleau J, Talajic M, Essebag V, Skanes A, Wilton SB, Verma A, Healey JS, Tang AS.
    Am Heart J; 2021 Apr 11; 234():90-100. PubMed ID: 33472052
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK, Park JJ, Lim NK, Kim WH, Choi DJ.
    Heart; 2020 Aug 11; 106(15):1160-1168. PubMed ID: 32341140
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
    Ullah W, Ling LH, Prabhu S, Lee G, Kistler P, Finlay MC, Earley MJ, Sporton S, Bashir Y, Betts TR, Rajappan K, Thomas G, Duncan E, Staniforth A, Mann I, Chow A, Lambiase P, Schilling RJ, Hunter RJ.
    Europace; 2016 May 11; 18(5):679-86. PubMed ID: 26843584
    [Abstract] [Full Text] [Related]

  • 19. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure: CASTLE-AF Trial.
    Sohns C, Zintl K, Zhao Y, Dagher L, Andresen D, Siebels J, Wegscheider K, Sehner S, Boersma L, Merkely B, Pokushalov E, Sanders P, Schunkert H, Bänsch D, Mahnkopf C, Brachmann J, Marrouche NF.
    Circ Arrhythm Electrophysiol; 2020 Oct 11; 13(10):e008461. PubMed ID: 32903044
    [Abstract] [Full Text] [Related]

  • 20. Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Oraii A, McIntyre WF, Parkash R, Kowalik K, Razeghi G, Benz AP, Belley-Côté EP, Conen D, Connolly SJ, Tang ASL, Healey JS, Wong JA.
    JAMA Cardiol; 2024 Jun 01; 9(6):545-555. PubMed ID: 38656292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.